Yanle Zhi

529 citations
27 papers · 444 indexed · h-index 12
Topics
Acute Myeloid Leukemia Research (8 papers)Protein Degradation and Inhibitors (6 papers)Multiple Myeloma Research and Treatments (5 papers)
Partner nations
ChinaSingapore

In The Last Decade

Yanle Zhi

25 papers receiving 441 citations

Peers

Yanle Zhi
Comparison fields: 5 of 47
  • Molecular Biology 264
  • Hematology 144
  • Organic Chemistry 143
  • Oncology 65
  • Genetics 44
Replace Anthony M. Slater with:
Anthony M. Slater United Kingdom
Aleksandr Kolesnikov United States
Zhaozhong J. Jia United States
Chao Yao China
Lawrence J. Mersinger United States
Hansen Wong United States
John Woolfrey United States
Christopher P. Tinworth United Kingdom
Katarzyna Kempińska Poland
Yasunori Hase Japan
Yanle Zhi relative to Anthony M. Slater United Kingdom Anthony M. Slater's profile →
Citations per field
00.5×4.6×
Anthony M. Slater · 1×
Citations per year

Countries citing papers authored by Yanle Zhi

Since Specialization
Citations

This map shows the geographic impact of Yanle Zhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanle Zhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanle Zhi more than expected).

Fields of papers citing papers by Yanle Zhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanle Zhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanle Zhi. The network helps show where Yanle Zhi may publish in the future.

Co-authorship network of co-authors of Yanle Zhi

This figure shows the co-authorship network connecting the top 25 collaborators of Yanle Zhi. A scholar is included among the top collaborators of Yanle Zhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanle Zhi. Yanle Zhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 11
6 5
7 8
8 2
9 2
10 8
11 7
12 13
13 7
14 17
15 18
16 89
17 24
18 21
19 27
20 57

About Yanle Zhi

Yanle Zhi is a scholar working on Hematology, Molecular Biology and Complementary and alternative medicine, having authored 27 papers that have together received 444 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (144 citations), Organic Chemistry (143 citations) and Genetics (44 citations). Yanle Zhi has collaborated with scholars based in China and Singapore. Frequent co-authors include Tao Lu, Yadong Chen, Tao Lu, Shuai Lü, Yue Wang, Xiaowei Dou, Na Liu, Baoquan Li, Zhimin Zhang and Hongmei Li. Their work appears in journals such as Journal of Agricultural and Food Chemistry, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026